MIM
SMTI icon

Monashee Investment Management’s Sanara MedTech SMTI Stock Holding History

Monashee Investment Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,060
Closed -$1.37M – 466
2021
Q1 		$1.37M Buy
+44,060
New +$1.53M 0.21% 143

Other funds holding SMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Monashee Investment Management's SMTI Position: Q2 2021 in Review

Monashee Investment Management sold out of Sanara MedTech (SMTI) in Q2 2021, closing a stake of 44,060 shares — an estimated $1.37M sold.

Monashee Investment Management first reported a position in SMTI in Q1 2021 and held it in 1 quarter. The position peaked at $1.37M in Q1 2021. 21 funds tracked by Wall St. Rank hold SMTI as of Q2 2021.

  • Monashee Investment Management reported no remaining Sanara MedTech position as of Q2 2021 after selling out during the quarter.
  • Monashee Investment Management sold 44,060 Sanara MedTech shares in Q2 2021, an estimated $1.37M.
  • Monashee Investment Management first reported a position in Sanara MedTech in Q1 2021 and held it in 1 quarter.
  • Monashee Investment Management's Sanara MedTech position peaked at $1.37M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2021.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.